Orbit Genomics’ game changing OrbiSeq™ technology platform analyzes novel genomic markers that uniquely reflect not only inherited predisposition to disease, but also risk acquired from lifestyle and environmental exposures, enabling diagnosis, treatment and ultimately prevention of complex diseases such as cancer, heart disease and Alzheimer’s disease.
